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Introduction. Optimal glycaemic control in women with gestational diabetes mellitus (GDM) reduces maternal and infant
morbidity. Method. A survey was administered to women diagnosed with GDM to explore their views and experiences in
achieving optimal glycaemic control. Results. Sixty women participated. Enablers included being taught to test capillary blood
glucose in group settings where the health professional demonstrated this on themselves ﬁrst (60, 100%); health professionals
listening (41, 68%); being reminded to perform blood glucose testing (33, 55%); and being provided healthy meals by friends
and family (28, 47%). Barriers included not having information in a woman’s ﬁrst language (33, 55%); being oﬀered unhealthy
food (19, 31%); not being believed by health professionals (13, 21%); receiving inconsistent information by health professionals
(10, 16%); never being seen twice by the same health professional (8, 13%); and long waiting hours at clinics (7, 11%). Two-thirds
of women (37, 62%) reported that food costs were not a barrier, but that they were always or frequently hungry. Conclusion.
Optimising experiences for women with GDM for achieving glycaemic control and overcoming barriers, regardless of glycaemic
targets, requires further focus on providing meaningful health literacy and support from health professionals, family, friends,
and work colleagues.
1. Introduction
Globally, there are increasing rates of diabetes, including
gestational diabetes mellitus (GDM) [1, 2]. The prevalence
of GDM varies among populations but probably aﬀects
10–25% of pregnancies [3–5].
Short- and long-term health risks for women with GDM
include preeclampsia, induction of labour, caesarean section,
and postnatal depression for the women [6–8]. For the
baby, health risks include shoulder dystocia, nerve palsy,
preterm birth, neonatal hypoglycaemia, respiratory distress
syndrome, and the risk of developing obesity and type 2
diabetes (T2DM) in childhood [9–11].
Treatments for women with GDM that maintain gly-
caemic control within speciﬁed targets have a signiﬁcant
impact on short- and long-term health for the woman
and her baby [12–14]. Treatments for GDM include dietary
and exercise advice alone or combined with pharmacological
therapy [15–19].
While some published studies have described women’s
experiences of developing gestational diabetes [20–25], little
is known as to how women feel about achieving their glycae-
mic treatment targets. This nested study within the TAR-
GET trial (Australian New Zealand Trial Registry:
ACTRN12615000282583) aimed to explore women’s views
and experiences in achieving their recommended glycae-
mic treatment targets and to identify potential barriers
and enablers.
2. Materials and Methods
2.1. Participant Selection.Women diagnosed with GDMwere
eligible to participate if they had a singleton pregnancy, could
communicate in English, had been self-monitoring their
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capillary blood glucose levels for at least two weeks, and
provided written consent. Eligible women were sent an email
invitation that included a participant information sheet and
consent form. Women could choose to be interviewed face
to face, or to be telephoned. Women were aware that the
survey was not an assessment of their knowledge about
GDM and advised that all their information would be
kept conﬁdential.
Hospital sites from two diﬀerent geographical locations
in New Zealand participated. Twenty women, recruited
from Canterbury District Health Board (DHB) in the
South Island, were using less tight glycaemic treatment
targets (fasting blood glucose< 5.5mmol/L, 1 hour postpran-
dial< 8.0mmol/L, and 2 hours postprandial< 7.0mmol/L).
Forty women were using tighter glycaemic treatment tar-
gets (fasting blood glucose≤ 5.0mmol/L, 1 hour postpran-
dial≤ 7.4mmol/L, and 2 hours postprandial≤ 6.7mmol/L):
twenty women recruited from Canterbury DHB in the
South Island and twenty women recruited from Counties
Manukau DHB in the North Island.
Local hospital policies diﬀered for testing of capillary
blood glucose. Canterbury DHB moved from initially less
tight targets to tighter glycaemic treatment targets during
the survey time. Women were asked to test their capillary
blood glucose at one hour postprandial. Counties Manukau
DHB was using tighter glycaemic treatment targets during
the survey time. Women were asked to test their capillary
blood glucose two hours postprandial.
2.2. The Survey. The survey comprised 45 questions. Twenty
questions identiﬁed participant demographics and twenty-
ﬁve their views and knowledge of their glycaemic treatment
targets. Questions included identifying what had been helpful
in learning how to self-monitor blood glucose levels; support
received from family, friends, and health professionals;
access to written information; costs associated with their
GDMmanagement and treatment; and experience of hunger.
The survey was piloted with three women following which
three questions were modiﬁed. There was an opportunity
for women to provide additional information. All women
answered all the survey questions.
2.3. Analysis.Data analysis was conducted using Pivot Tables
in Microsoft Oﬃce Excel 2016 calculating frequency and
corresponding percentage to describe the responses to the
survey questions and included mean and standard deviation
for normally distributed data. All analyses were undertaken
in Microsoft Oﬃce Excel 2016, reporting descriptive statistics
for baseline demographics and using simple numeric calcula-
tions for survey responses.
2.4. Ethical Approval. The Views Survey was nested within
the TARGET trial approved by the New Zealand Health
and Disability Ethics committee (HDEC) Ref. 14/NTA/163
and research registration number 1965.
3. Results
3.1. Participants. Sixty-six eligible women were approached
and sixty women consented to participate in the survey. Six
women did not participate because they were too busy,
having a family crisis, or not responding to the invitations
(Figure 1). Face-to-face surveys were conducted with 34
(57%) women and 26 (43%) of the women chose to be
surveyed by telephone. The average age of the participating
women was 33 years (standard deviation (SD)± 4.5). Just
under half of the women were primigravid and had a family
history of diabetes (27, 45%), and two-thirds were classiﬁed
as obese or overweight in early pregnancy (39, 65%)
(Table 1). Most women were European (24, 40%) followed
by Asian ethnicity (22, 37%). Women taking part were evenly
distributed across the deprivation index: 18 (30%) women
least deprived (levels 1–3) and 19 (32%) women (levels
4–6) and 22 (37%) women most deprived (levels 7–10)
Eligible women approached
n = 66
Women declined or unable to be contacted
n = 6






Family crisis (1 woman)
Nondelivered email, not answering (1 woman)
(iii) Too busy (2 women)
Reason for declining
Counties Manukau DHB
(i) Nondelivered email, not answering (2 women)
n = 22Counties Manukau DHBn = 44Canterbury DHB
n = 2Counties Manukau DHBn = 4Canterbury DHB
n = 20Counties Manukau DHBn = 40Canterbury DHB
Figure 1: Flowchart of recruitment.
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(Table 1). The demographics of the participating women
are reﬂective of a cross section of the demographics of
New Zealand’s pregnant population [26–28] (Table 1).
Women were diagnosed with GDM at a mean of 27.8±
2.0-week gestation. At the time of the survey, participants
had been checking their daily capillary blood glucose for an
average of 6.8± 2.3 weeks (Table 1), with just over half
checking their blood glucose four times a day (32, 53%) and
the other participants six times a day (28, 47%). Ten women
(17%) reported having a diagnosis of GDM from a previous
pregnancy. Almost a third of women (18, 30%) were treated
with diet alone; the remainder received a combination of
dietary advice and medications. Thirteen (22%) women were
treated with subcutaneous insulin for their GDM, 17 (28%)
women metformin, and 12 (20%) women were treated with
insulin and metformin (Table 1).
3.2. Views and Experiences about Achieving Recommended
Glycaemic Treatment Targets. The majority of women cor-
rectly identiﬁed their glycaemic treatment targets (59, 98%)
and viewed it as very important or important to try to adhere
to these targets (Table 2). Documenting the blood glucose
results were viewed as less important (56, 93%) compared
to viewing adherence to the targets because women knew
the results could be downloaded from the glucometer. These
ﬁndings were similar across participants regardless of their
glycaemic treatment targets (Table 2).
Almost two-thirds of women (37, 62%) described achiev-
ing their morning fasting glycaemic treatment target as
most diﬃcult. These ﬁndings were similar across partici-
pants, regardless of their recommended glycaemic targets
(12 (60%) for less tight targets and 25 (62.5%) for tighter
targets) (Table 2). The next most frequent diﬃculty reported
for women to achieve their recommended glycaemic targets
was after their evening meal (11, 18%). Again, these ﬁnd-
ings were similar across participants regardless of their
glycaemic treatment targets (Table 2). Almost two-thirds
of women (37, 62%) experienced being always or frequently
hungry (Table 3).
3.3. Enablers to Achieving Optimal Blood Glucose Control.
Participants were asked to identify what helped them when
learning to test their capillary blood glucose levels. All 60
(100%) women indicated that having a health professional
to demonstrate the collection of capillary blood glucose on
themselves and then watch the participant perform it was
helpful (Table 3). Fifty-six (93%) women opted to comment
further about other factors that they felt were helpful for
learning self-monitoring of blood glucose. These related
mainly to group or individual teaching. Forty-four (79%) of
the women who commented further stated that they found
group sessions helpful with some women explaining that
they enjoyed talking to other women and recognising that
they are not alone living with GDM. A smaller proportion
of women (12, 21%) received additional one-to-one teaching
sessions and enjoyed them as these enabled them to ask
“stupid” questions, they could ask the teacher to slow down
when English was their second language, or they felt less as
though it was “mass produced” and liked to be treated more
as an individual. Over a third of women (22, 37%) identiﬁed
Google as a helpful tool. It is unclear which websites they
visited and in which language.
Support from family, friends, and work colleagues was
seen as enabling for achieving glycaemic control. Over half
of the women (33, 55%) indicated that they found it helpful
to be asked about their capillary blood glucose levels and to
be reminded to do them by their partners, children, extended
family members, and work colleagues. Having their meals
cooked by either their partners or extended family members,
who incorporated the GDM diet recommendations, was
found to be helpful for nearly half of the women (28, 47%)
(Table 4). Comments indicated that this enabled women to
eat more vegetables and stopped them from buying confec-
tionary or sugar-sweetened beverages (ﬁzzy drinks). Further
comments around supportive provision of food by others
included colleagues organising healthy morning teas at work
and friends providing healthy food choices for baby showers.
While nearly two-thirds of women (37, 62%) indicated
that the cost associated with the GDM diagnosis, such as
food, petrol, or child care, stayed the same, some women
(8, 13%) reported reduced food costs since being diagnosed
with GDM as an enabler due to buying fewer take-away
meals (fast foods) (Table 3).
All women attended Diabetes in Pregnancy Services
where they saw a range of health professionals. Most women
(47, 78%) attended the clinic fortnightly (Table 4). Support
from health professionals was valued. Over two-thirds of
the women (41, 68%) appreciated that health professionals
took time to listen and explain (Table 3). One (1.7%) woman
could email the endocrinologist for advice and appreciated
their prompt response.
3.4. Barriers to Achieving Optimal Blood Glucose Control. All
women received written information about GDM, which
explained the importance of healthy eating and its eﬀect on
blood glucose levels and how to self-monitor capillary blood
glucose levels. Barriers to this written information included
feeling overwhelmed with the amount of written material
and not being able to read it in their ﬁrst language. Women
requested to receive visual information (16, 27%) rather
than words for food choices, food label reading, how to
perform the ﬁnger pricks for capillary blood glucose collec-
tion, and how to give subcutaneous insulin injections
(Table 4). Over half of the women (33, 55%) found it diﬃcult
that the written information was in English and wanted the
health information in their ﬁrst language for themselves
and for their families to better understand what GDM is
and what optimal blood glucose control meant (Table 4).
Hindi was the language most frequently requested (9, 27%
women), followed by Samoan (6, 18% women) and then
Chinese and Māori each by 5 (15%) women. This reﬂects
the ethnic diversity of this cohort of women (Table 1).
Over a third of women (23, 38%) reported being oﬀered
unhealthy food by family, friends, and work colleagues and
their lack of understanding as barriers to achieving optimal
glycaemic control.
When engaging with the Diabetes in Pregnancy Services
women, just over a ﬁfth of women (13, 22%) reported a
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Table 1: Demographic characteristics of women who participated in the survey.
Characteristics
Women with less tight1
glycaemic treatment targets
n = 20 (% or ±20)
Women with tighter2
glycaemic treatment targets




Age (years)4 34 (±4.3) 32 (±4.5) 33 (±4.5)
Primigravida (G1P0)
3 9 (45) 18 (45) 27 (45)
BMI category5,3
Normal 8 (40) 13 (32.5) 21 (35)
Overweight 5 (25) 6 (15) 11 (18.3)
Obese (class I) 2 (10) 9 (22.5) 11 (18.3)
Obese (class II) 2 (10) 6 (15) 8 (13.3)
Obese (class II) 3 (15) 6 (15) 9 (15)
Total obese 7 (35) 21 (52.5) 28 (46.6)
Ethnicity6,3
European 12 (60) 12 (30) 24 (40)
Māori — 6 (15) 6 (10)
Asian 7 (35) 15 (37.5) 22 (36.7)
Paciﬁc Peoples — 7 (17.5) 7 (11.6)
MELAA 1 (5) — 1 (1.7)
Highest educational qualiﬁcations after leaving school7,3
(1) No qualiﬁcation 1 (5) 2 (5) 3 (5)
(2) Level 1 certiﬁcate — 2 (5) 2 (3.3)
(3) Level 2 certiﬁcate 2 (10) 2 (5) 4 (6.7)
(4) Level 3 certiﬁcate 2 (10) 4 (10) 6 (10)
(5) Level 4 certiﬁcate — 4 (10) 4 (6.7)
(6) Level 5 and level 6 diploma 4 (20) 9 (22.5) 13 (21.7)
(7) Bachelor degree and level 7 qualiﬁcation 8 (40) 17 (42.5) 25 (41.6)
(8) Postgraduate and honours degree 1 (5) — 1 (1.7)
(9) Master’s degree 2 (10) — 2 (3.3)
NZ deprivation index8,3
1 (least deprived) 3 (15) 5 (12.5) 8 (13.5)
2 2 (10) 3 (7.5) 5 (8.4)
3 2 (10) 3 (7.5) 5 (8.4)
4 4 (20) 6 (15) 10 (16.7)
5 2 (10) 5 (12.5) 7 (11.8)
6 1 (5) 1 (1.7) 2 (3.4)
7 2 (10) 3 (7.5) 5 (8.5)
8 3 (15) 3 (7.5) 6 (10)
9 1 (5) 4 (10) 5 (8.7)
10 (most deprived) — 6 (15) 6 (10)
Lead maternity carer (LMC)9,3
Midwife 19 (95) 36 (90) 55 (91.7)
Obstetrician 1 (5) — 1 (1.7)
Hospital team — 4 (10) 4 (6.7)
Gestational age at GDM diagnosis4 (weeks) 27.7 (±1.9) 27.9 (±2.0) 27.8 (±2.0)
Time of self-testing capillary blood glucose for (weeks)4 7.6 (±2.5) 6.4 (±2.1) 6.8 (±2.3)
Previous GDM3 4 (20) 6 (15) 10 (16.7)
Previous hypertension3 2 (10) — 2 (3.3)
Current hypertension — 3 (7.5) 3 (5)
Family history of hypertension3 8 (45) 16 (40) 24 (40)
4 Journal of Diabetes Research
judgemental attitude by health professionals, being impatient
with them, and being not believed that they had tried their
hardest to stay within their recommended glycaemic treat-
ment targets as a barrier. Inconsistent information by health
professionals (10, 17%), never seeing the same health pro-
fessional twice (8, 13%), and long waiting hours at the
clinic (7, 12%) were also experienced as diﬃcult (Table 4).
An increased cost for buying more vegetables, fresh
fruits, and wholemeal bread was reported as a barrier by a
quarter of women (15, 25%) (Table 4).
4. Discussion
In this survey, women with GDM identiﬁed enablers
and barriers to achieving optimal glycaemic control. While
achieving optimal glycaemic control was viewed as
important, most women found it diﬃcult to achieve their
morning fasting glycaemic treatment targets, experienced
hunger, and wanted the health information in their ﬁrst lan-
guage or visually displayed. For most women, food costs were
not reported as a concern for the family budget. Being taught
blood glucose testing in a group setting was considered help-
ful. Support from health professionals and family, friends,
and work colleagues was valued. Barriers reported include
long clinic waiting hours; inconsistent advice, judgemental
attitudes, impatience, and not being believed by health
professionals; and unhealthy food being oﬀered by family
members, friends, and work colleagues.
Health care providers recognise that teaching moments
can be maximised by incorporating speciﬁc adult-learning
principles and learning styles into their teaching strategies
and providing written information that supports these
Table 1: Continued.
Characteristics
Women with less tight1
glycaemic treatment targets
n = 20 (% or ±20)
Women with tighter2
glycaemic treatment targets




Family history of diabetes3 7 (35) 20 (50) 27 (45)
Current smoker3 — 3 (7.5) 3 (15)
Current treatment3
Diet only 7 (35) 11 (27.5) 18 (30)
Insulin and diet 2 (10) 11 (27.5) 13 (21.7)
Metformin and diet 5 (25) 12 (30) 17 (28.3)
Insulin, metformin, and diet 6 (30) 6 (15) 12 (20)
1Less tight glycaemic treatment targets for women with GDM: fasting blood glucose < 5.5 mmol/L, 1 hour postprandial < 8.0 mmol/L, and 2 hours
postprandial < 7.0 mmol/L; 2tighter glycaemic treatment targets for women with GDM: fasting blood glucose ≤ 5.0 mmol/L, 1 hour postprandial ≤ 7.4 mmol/L,
and 2 hours postprandial ≤6.7 mmol/L; 3ﬁgures are numbers and percentages; 4ﬁgures are mean and standard deviation; 5BMI categories:
underweight < 18.50, normal range ≥ 18.55–24.99, overweight ≥ 25.00–29.99, obese (class I) ≥ 30.00–34.99, obese (class II)—severe obese ≥ 35.00–39.99
and obese (class II)—morbid obese ≥ 40.00 (according to WHO and Ministry of Health categories) [44, 45]; 6as categorised by New Zealand
government statistics groups for major ethnic groups. MELAA is an acronym for Middle Eastern/Latin American/African (http://www.stats.govt.nz/
Census/2013-census/proﬁle-and-summary-reports/infographic-culture-identity.aspx); 7as categorised by New Zealand government statistics groups
(http://www.stats.govt.nz/Census/2013-census/proﬁle-and-summary-reports/qstats-education-training/highest-qualiﬁcation.aspx); 8as categorised by New
Zealand 2013 Deprivation Index, University of Otago, Department of Public Health. Deprivation score was unknown for one woman, as her address
had no meshblock listed (http://www.otago.ac.nz/wellington/departments/publichealth/research/hirp/otago020194.html); 9a lead maternity carer (LMC) in
New Zealand provides lead maternity care (is in charge). This can be either a midwife, obstetrician, or GP (https://www.midwife.org.nz/in-new-zealand/
contexts-for-practice).
Table 2: Participants views and experiences of capillary blood glucose monitoring.
Women with less tight
glycaemic treatment targets
n = 20 (% of 20)
Women with tighter
glycaemic treatment targets
n = 40 (% of 40)
Women total
n = 60 (%)
Knew their glycaemic treatment targets 19 (98.3) 40 (100) 59 (98.3)
Viewed achieving glycaemic treatment targets as
very important or important
20 (100) 39 (97.5) 59 (98.3)
Viewed documenting blood glucose results as
very important or important
18 (90) 37 (92.5) 56 (93.3)
Experienced diﬃcult fasting glycaemic treatment
target (before breakfast)
12 (60) 25 (62.5) 37 (61.6)
Experienced diﬃcult postprandial glycaemic treatment
target (after dinner)
3 (15) 8 (20) 11 (18.3)
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learning styles [29]. The survey results showed that partici-
pants wished to be provided with better visual information
and to have written information in their own language. Most
women enjoyed group teaching sessions, although some
preferred one-to-one sessions.
We found no published studies reporting on the eﬀects of
providing visual learning aids for women with gestational
diabetes or the impact of having the information in their ﬁrst
language. One mixed-method study [30] among young
people with type 1 diabetes (T1DM) in Norway found that
a pictorial diary as a mobile phone app covering the
topics diet, insulin dosage, physical activity, and pre- and
postprandial glucose measurements all led to a change in
the participants’ applied knowledge about the management
of their diabetes. This is an area requiring further research.
For information to make sense and motivate behaviour
change, it needs to be provided in a language best understood
by the women with GDM [23–25, 31]. Women identiﬁed
Google as a helpful tool. Health professionals need to be
aware that women will access information beyond the clinic
environment and the quality of this information may vary.
Diabetes in Pregnancy Services should consider how they
provide health information and the content of their teaching
sessions. Health literacy providing clear and relevant health
messages has been identiﬁed as an eﬀective way to help
people manage their own health care [31–34]. It would be
challenging for Diabetes in Pregnancy Services to provide
the information for women with GDM in all the languages
identiﬁed through this survey. The solution may be to
provide increased visual information which requires little
language and/or translate the written information for the
languages identiﬁed. The use of trained translators has been
encouraged, as family members are often unfamiliar with
the health care medical terms, may ﬁnd it diﬃcult talking
about sensitive matters, and may have diﬀerent degrees of
English ﬂuency [35].
Achieving adequate fasting blood glucose control prior to
breakfast, also known as the dawn phenomenon [36], was
identiﬁed as a challenge for most women in this survey,
regardless of whether their recommended glycaemic targets
Table 3: Enablers identiﬁed by women with GDM1.
Enablers
Women with less tight
glycaemic treatment targets
n = 20 (% of 20)
Women with tighter
glycaemic treatment targets
n = 40 (% of 40)
Women total
N = 60 (%)
Health professional demonstrating on themselves CBGT2 20 (100) 40 (100) 60 (100)
Watching participants perform CBGT2 20 (100) 40 (100) 60 (100)
Group teaching 11 (55) 33 (82.5) 443 (78.5)
One to one teaching 6 (30) 6 (15) 123 (21.4)
Health professionals listening and explaining 6 (30) 35 (87.5) 41 (68.3)
Being ask about their CBGC4 and reminded to do them 7 (35) 26 (65) 33 (55)
Others cooking incorporating GDM diet 11 (55) 17 (42.5) 28 (46.6)
Using Google 9 (45) 13 (32.5) 22 (36.6)
Going for walks/exercising together 6 (30) 9 (45) 15 (25)
Less costs 3 (15) 5 (12.5) 8 (13.3)
1Multiple answers were possible for this part of the survey; 2capillary blood glucose testing; 3results from 56 women; 4capillary blood glucose concentrations.
Table 4: Barriers identiﬁed by women with GDM.
Barriers
Women with less tight
glycaemic treatment targets
n = 20 (% of 20)
Women with tighter
glycaemic treatment targets
n = 40 (% of 40)
Women total
n = 60 (%)
Health information available only in English 8 (40) 25 (62.5) 33 (55)
Health information in words not visual 5 (25) 11 (27.5) 16 (26.6)
Being oﬀered unhealthy food by family, friends, and
work colleagues
5 (25) 14 (35) 23 (38.3)
Impatient, not being believed, and being judged by
health professionals
7 (35) 6 (15) 13 (21.6)
Inconsistent information by health professionals 4 (20) 6 (15) 10 (16.6)
Never seeing the same health professional twice 3 (15) 5 (12.5) 8 (13.3)
Long waiting hours at clinic 4 (20) 3 (7.5) 7 (11.6)
Being hungry 14 (70) 23 (57.5) 37 (61.6)
Increased costs 7 (35) 8 (20) 15 (25)
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were identiﬁed as less tight or tighter. In the literature, this
has been identiﬁed previously for people with T1DM and
T2DM [37] but we could not ﬁnd any publications speciﬁ-
cally relating to gestational diabetes. Anecdotal evidence
through social media indicates that women with GDM do
ﬁnd this control diﬃcult [38]. Various recommendations
for achieving glycaemic control include subcutaneous insu-
lin, walking after dinner, restricting carbohydrate intake at
dinner time, late protein snack before bed time, and staying
hydrated [39] but require further research for women with
GDM. Two-thirds of women commented on being hungry.
It is unclear from the survey if this relates to women trying
to lower their morning fasting blood glucose with eating less
at dinner time or eating very low carbohydrate meals. This
would beneﬁt from further exploration.
Some women identiﬁed barriers regarding health profes-
sional’s attitude to not achieving adequate glycaemic control.
These included judgemental attitude, not being believed
when women stated that they were trying their hardest to
follow all diet and pharmaceutical recommendations, and
seeing a diﬀerent health professional at each visit receiving
inconsistent information. Findings from other qualitative
studies reiterate these ﬁndings [31, 40, 41] and highlight
the importance for health professional to have a woman-
centred approach, not only focusing on blood glucose con-
centrations but investing time to listen, believing what the
women say is true, and providing consistent information
and continuity of care [41].
Support from family, friends, and work colleagues were
appreciated by the women surveyed. These results are consis-
tent with those of other studies [42, 43]. Barrier identiﬁcation
included unhealthy food being oﬀered to them by family
members, friends, and work colleagues, indicating a lack of
understanding. Diabetes in Pregnancy Services may consider
providing opportunity for family and friends to attend
information sessions about GDM and its implication or
include discussions about eﬀective strategies for diﬃcult
situations at clinic appointments.
This study had some limitations. The participants were
from two selected areas in New Zealand, and while they were
a cross-sectional representation of the demographics of the
New Zealand population, this did not include women living
in rural or remote areas. The ﬁndings may not be generalised
as diﬀerent district health boards provide care for women
with GDM through diﬀerent models of care.
5. Conclusions
This survey identiﬁed barriers and enablers for women with
GDM in achieving optimal glycaemic control from two
diﬀerent geographical locations in New Zealand. The results
provide insights into women’s views and experiences with
GDM in achieving glycaemic control targets. Two-thirds of
women found it diﬃcult to achieve adequate fasting capillary
blood glucose control, regardless of their recommended gly-
caemic targets, and identiﬁed the need for better strategies
and adequate health professional and family support to
manage this diﬃculty. Barriers for health information and
literacy identiﬁed that health professionals need to consider
using a women-centred and adult-learning style approach,
provide visual aids, provide written information in relevant
languages, and include extended family members when
imparting knowledge on or teaching GDM-related skills.
Long clinic waiting hours, inconsistent advice, judgemental
attitudes, and not being believed by health professionals
require further consideration when providing a health care
service for women with GDM. Findings from this survey will
be useful for developing strategies for Diabetes in Pregnancy
Services to support women with GDM in achieving their
glycaemic control.
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